Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene

Mayo Clinic Proceedings

Volumn 77, Issue 6, 2002, Pages 522-530

  Waalen, Jill ^a   Felitti, Vincent ^b   Gelbart, Terri ^a   Ho, Ngoc J ^a   Beutler, Ernest ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE; GENE MUTATION; HEMOCHROMATOSIS; HFE GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MUTATION RATE; PREVALENCE; QUESTIONNAIRE; SYMPTOM;

EID: 0036264177     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.6.522     Document Type: Article

References (23)

1. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
2. Global prevalence of putative haemochromatosis mutations
3. A population-based study of the clinical expression of the hemochromatosis gene
4. A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment
5. Disease-related conditions in relatives of patients with hemochromatosis
6. Homozygosity for hemochromatosis: Clinical manifestations
7. The morbidity of hemochromatosis among clinically unselected homozygotes: Preliminary report
8. Population screening for haemochromatosis: A unifying analysis of published intervention trials
9. Clinical features of genetic hemochromatosis in women compared with men
10. Clinical presentation of hemochromatosis: A changing scene
11. Hereditary hemochromatosis: Presentation and diagnosis in the 1990s
12. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis
13. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
14. EASL International Consensus Conference on Haemochromatosis, part II: Expert document
15. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
16. Large-scale screening for HFE mutations: Methodology and cost
17. Screening for hemochromatosis: A cost-effectiveness study based on 12,258 patients
18. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria
19. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers
20. Practice Guideline Development Task Force of the College of American Pathologists. Hereditary hemochromatosis
21. The continuing epidemics of obesity and diabetes in the United States
22. Prevalence of iron deficiency in the United States